| Business Summary | | Sabratek
Corporation
develops,
produces
and
markets
therapeutic
and
diagnostic
medical
systems
designed
specifically
to
meet
the
needs
of
the
alternate-site
healthcare
market.
Sabratek's
multi-therapy
infusion
and
other
devices
and
data
management
systems
incorporate
advanced
communications
technology,
which
is
designed
to
reduce
provider
operating
costs
while
maintaining
the
integrity
and
quality
of
care.
The
Company's
proprietary
health
care
information
system
provides
remote
programming
as
well
as
real-time
diagnostic
and
therapeutic
data
capture
capabilities,
allowing
caregivers
to
monitor
patient
compliance
more
effectively
and
allowing
providers
to
develop
outcome
analyses
and
optimal
clinical
protocols.
The
Company
has
designed
its
integrated
hardware
and
software
system
to
permit
health
care
providers
to
achieve
cost-effective
movement
of
patients
along
the
continuum
of
alternate-site
health
care
settings. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | SBTKQ
develops,
produces
and
markets
therapeutic
and
diagnostic
medical
systems
designed
specifically
to
meet
the
needs
of
the
alternate-site
healthcare
market.
For
the
three
months
ended
3/31/99,
revenues
decreased
10%
to
$13.6
million.
Net
income
decreased
62%
to
$726
thousand.
Revenues
reflect
the
suspension
of
distribution
of
the
Rocap
product
line.
Earnings
also
reflect
increased
S/G/A
expenses
due
to
the
expansion
of
the
direct
sales
force
and
higher
debt
levels. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY1998
Compensation | | Pay | Exer | |
| K. Padda, 36 Chairman
and CEO | $408K | -- | Stephen Holden, 45 Pres
and Treasurer | 290K | $77K | Paul Jurewicz, 43 Sr.
VP and CFO | 79K | -- | Scott Skooglund, 40 VP
of Fin. | -- | -- | Vincent Capponi, 41 VP
and COO. | 216K | 105K | Dollar amounts are as of 31-Dec-1998 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|